Breakthrough asthma study aims to cut daily meds for severe sufferers

NCT ID NCT06473779

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing if a biologic drug called tezepelumab can help people with severe, hard-to-control asthma safely reduce the amount of their daily steroid inhaler medicine. About 326 teens and adults will receive tezepelumab injections. The main goal is to see if they can lower their daily medication dose over a year without their asthma getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Palmdale, California, 93551, United States
Research Site

Colorado Springs, Colorado, 80907, United States
Research Site

Miami, Florida, 33136, United States
Research Site

Boston, Massachusetts, 02115, United States
Research Site

St Louis, Missouri, 63110, United States
Research Site

New Brunswick, New Jersey, 08901, United States
Research Site

Oklahoma City, Oklahoma, 73120, United States
Research Site

McAllen, Texas, 78503, United States
Research Site

Berazategui, 1104, Argentina
Research Site

CABA, C1012AAR, Argentina
Research Site

Concepción del Uruguay, 3260, Argentina
Research Site

Mendoza, 5500, Argentina
Research Site

Mendoza, M5500CCG, Argentina
Research Site

Quilmes, B1878FNR, Argentina
Research Site

Rosario, 2000, Argentina
Research Site

Rosario, 2002, Argentina
Research Site

San Miguel de Tucumán, 4000, Argentina
Research Site

Santa Fe, 3000, Argentina
Research Site

Anderlecht, 1070, Belgium
Research Site

Edegem, 2650, Belgium
Research Site

Erpent, 5101, Belgium
Research Site

Ghent, 9000, Belgium
Research Site

Liège, 4000, Belgium
Research Site

Haskovo, 6300, Bulgaria
Research Site

Pleven, 5804, Bulgaria
Research Site

Razgrad, 7200, Bulgaria
Research Site

Rousse, 7002, Bulgaria
Research Site

Sofia, 1154, Bulgaria
Research Site

Sofia, 1431, Bulgaria
Research Site

Stara Zagora, 6003, Bulgaria
Research Site

Velika Tarnovo, 5250, Bulgaria
Research Site

Vancouver, British Columbia, V5Z 1M9, Canada
Research Site

Ajax, Ontario, L1S 2J5, Canada
Research Site

Windsor, Ontario, N8X 1T3, Canada
Research Site

Québec, Quebec, G1V 4G5, Canada
Research Site

Sherbrooke, Quebec, J1H 5N4, Canada
Research Site

Regina, Saskatchewan, S7N 5A2, Canada
Research Site

Aalborg, 9000, Denmark
Research Site

Hvidovre, 2650, Denmark
Research Site

Svendborg, 5700, Denmark
Research Site

Vejle, 7100, Denmark
Research Site

Créteil, 94000, France
Research Site

La Tronche, 38700, France
Research Site

Lyon, 69004, France
Research Site

Marseille, 13915, France
Research Site

Montpellier, 34295, France
Research Site

Strasbourg, 67091, France
Research Site

Augsburg, 86150, Germany
Research Site

Bonn, 53127, Germany
Research Site

Cottbus, 03050, Germany
Research Site

Hanover, 30625, Germany
Research Site

Mainz, 55128, Germany
Research Site

Florence, 50134, Italy
Research Site

Orbassano, 10043, Italy
Research Site

Roma, 00161, Italy
Research Site

Roma, 00168, Italy
Research Site

Verona, 37134, Italy
Research Site

Chihuahua City, 31200, Mexico
Research Site

Cuauhtémoc, 06700, Mexico
Research Site

Monterrey, 64360, Mexico
Research Site

Badalona(Barcelona), 08916, Spain
Research Site

Barcelona, 08035, Spain
Research Site

Lugo, 27002, Spain
Research Site

Madrid, 28006, Spain
Research Site

Madrid, 28040, Spain
Research Site

Madrid, 28041, Spain
Research Site

Belfast, BT9 7BL, United Kingdom
Research Site

Liverpool, L7 8XP, United Kingdom
Research Site

London, SE1 9RT, United Kingdom
Research Site

Southampton, SO16 6YD, United Kingdom

Conditions

Explore the condition pages connected to this study.

SEVERE ASTHMA